trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adenocarcinoma, Papillary D000231 2 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Alzheimer Disease D000544 76 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Asthma D001249 52 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Body Weight D001835 333 associated lipids
Brain Neoplasms D001932 15 associated lipids
Breast Neoplasms D001943 24 associated lipids
Carcinoma D002277 18 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Cat Diseases D002371 12 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Chondrosarcoma D002813 9 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Endometriosis D004715 29 associated lipids
Enteritis D004751 8 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Fibrosis D005355 23 associated lipids
Fragile X Syndrome D005600 5 associated lipids
Ganglioneuroma D005729 2 associated lipids
Glioblastoma D005909 27 associated lipids
Glioma D005910 112 associated lipids
Goldenhar Syndrome D006053 1 associated lipids
Cardiomegaly D006332 31 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
von Hippel-Lindau Disease D006623 1 associated lipids
Hypersensitivity D006967 22 associated lipids
Hypertension D006973 115 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Hypesthesia D006987 1 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Inflammation D007249 119 associated lipids
Chromosome Inversion D007446 1 associated lipids
Keloid D007627 12 associated lipids
Leishmaniasis D007896 19 associated lipids
Leukemia D007938 74 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lupus Vulgaris D008177 1 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Medulloblastoma D008527 22 associated lipids
Melanoma D008545 69 associated lipids
Intellectual Disability D008607 13 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Opioid-Related Disorders D009293 5 associated lipids
Nasal Polyps D009298 26 associated lipids
Nasopharyngeal Neoplasms D009303 4 associated lipids
Neoplasms D009369 13 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Nerve Degeneration D009410 53 associated lipids
Neuroblastoma D009447 66 associated lipids
Osteomalacia D010018 5 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Progeria D011371 3 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Radiation Injuries D011832 14 associated lipids
Retinoblastoma D012175 12 associated lipids
Rubinstein-Taybi Syndrome D012415 1 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Osteosarcoma D012516 50 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Translocation, Genetic D014178 20 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Uveal Neoplasms D014604 3 associated lipids
Supratentorial Neoplasms D015173 1 associated lipids
Reperfusion Injury D015427 65 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Leukemia, Myelomonocytic, Acute D015479 6 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Polycystic Kidney, Autosomal Dominant D016891 6 associated lipids
Cicatrix, Hypertrophic D017439 4 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Bence M et al. Transcriptional modulation of monoaminergic neurotransmission genes by the histone deacetylase inhibitor trichostatin A in neuroblastoma cells. 2012 J Neural Transm pmid:21785940
Suh HS et al. Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes. 2010 J Neuroimmune Pharmacol pmid:20157787
Fleiss B et al. Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury. 2012 J Neuroinflammation pmid:22512781
Noro R et al. The anticancer effect of histone deacetylase inhibitors and combination with the cytotoxic agents in lung cancer cells: biological analyses for future clinical application. 2009 J Nippon Med Sch pmid:19305113
Por ED et al. Trichostatin A Inhibits Retinal Pigmented Epithelium Activation in an In Vitro Model of Proliferative Vitreoretinopathy. 2016 J Ocul Pharmacol Ther pmid:27494828
Sun G et al. Insights into the lysine acetylproteome of human sperm. 2014 J Proteomics pmid:25038526
Gavin DP et al. Histone deacetylase inhibitors and candidate gene expression: An in vivo and in vitro approach to studying chromatin remodeling in a clinical population. 2009 J Psychiatr Res pmid:19187942
Gavin DP et al. Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. 2009 J Psychiatry Neurosci pmid:19448855
Albertus DL et al. AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma. 2008 J Thorac Oncol pmid:18978557
Seo SK et al. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation. 2011 J Thorac Oncol pmid:21642861
Selinger CI et al. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. 2011 J Thorac Oncol pmid:21597389
Kakihana M et al. Induction of E-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition. 2009 J Thorac Oncol pmid:20009910
Kimura T et al. Chromium (VI) inhibits mouse metallothionein-I gene transcription by modifying the transcription potential of the co-activator p300. 2011 J Toxicol Sci pmid:21467744
Simões-Pires CA et al. Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS. 2017 J Vis Exp pmid:28829415
Azuma R et al. Combinational Treatment of Trichostatin A and Vitamin C Improves the Efficiency of Cloning Mice by Somatic Cell Nuclear Transfer. 2018 J Vis Exp pmid:29757287
Valapour M et al. Histone deacetylation inhibits IL4 gene expression in T cells. 2002 J. Allergy Clin. Immunol. pmid:11842291
Su RC et al. Epigenetic regulation of established human type 1 versus type 2 cytokine responses. 2008 J. Allergy Clin. Immunol. pmid:17980413
Milagre I et al. Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination. 2010 J. Alzheimers Dis. pmid:20930312
Kudo K et al. Biosynthetic Origin of the Hydroxamic Acid Moiety of Trichostatin A: Identification of Unprecedented Enzymatic Machinery Involved in Hydroxylamine Transfer. 2017 J. Am. Chem. Soc. pmid:28497964
Ren C et al. Peptide mass mapping of acetylated isoforms of histone H4 from mouse lymphosarcoma cells treated with histone deacetylase (HDACs) inhibitors. 2005 J. Am. Soc. Mass Spectrom. pmid:16099169
Yoshikawa M et al. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells. 2007 J. Am. Soc. Nephrol. pmid:17135397
Yu Z et al. Histone deacetylases augment cytokine induction of the iNOS gene. 2002 J. Am. Soc. Nephrol. pmid:12138131
Hou W et al. Hypoxia-induced deacetylation is required for tetraploid differentiation in response to testicular ischemia-reperfusion (IR) injury. 2012 Nov-Dec J. Androl. pmid:22556385
Fenic I et al. In vivo application of histone deacetylase inhibitor trichostatin-a impairs murine male meiosis. 2008 Mar-Apr J. Androl. pmid:18046049
Fenic I et al. In vivo effects of histone-deacetylase inhibitor trichostatin-A on murine spermatogenesis. 2004 Sep-Oct J. Androl. pmid:15292114
Shi LH et al. Trichostatin A and nuclear reprogramming of cloned rabbit embryos. 2008 J. Anim. Sci. pmid:18245503
Ueda JY et al. JBIR-17, a novel trichostatin analog from Streptomyces sp. 26634. 2009 J. Antibiot. pmid:19300468
Yoshida M et al. Structural specificity for biological activity of trichostatin A, a specific inhibitor of mammalian cell cycle with potent differentiation-inducing activity in Friend leukemia cells. 1990 J. Antibiot. pmid:2211374
Otoguro K et al. Screening for new antitrichomonal substances of microbial origin and antitrichomonal activity of trichostatin A. 1988 J. Antibiot. pmid:3372352
Takahashi I et al. Selective inhibition of IL-2 gene expression by trichostatin A, a potent inhibitor of mammalian histone deacetylase. 1996 J. Antibiot. pmid:8682722
Komatsu Y and Hayashi H Histone deacetylase inhibitors up-regulate the expression of cell surface MHC class-I molecules in B16/BL6 cells. 1998 J. Antibiot. pmid:9531994
Koguchi Y et al. Trichostatin A and herboxidiene up-regulate the gene expression of low density lipoprotein receptor. 1997 J. Antibiot. pmid:9592573
Kim YB et al. Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells. 2000 J. Antibiot. pmid:11132966
Dupré-Aucouturier S et al. Trichostatin A, a histone deacetylase inhibitor, modulates unloaded-induced skeletal muscle atrophy. 2015 J. Appl. Physiol. pmid:26112243
Jafari S et al. Epigenetic modification does not determine the time of POU5F1 transcription activation in cloned bovine embryos. 2011 J. Assist. Reprod. Genet. pmid:22020531
Slattery EL et al. Epigenetic influences on sensory regeneration: histone deacetylases regulate supporting cell proliferation in the avian utricle. 2009 J. Assoc. Res. Otolaryngol. pmid:19340485
Azechi T et al. Trichostatin A, an HDAC class I/II inhibitor, promotes Pi-induced vascular calcification via up-regulation of the expression of alkaline phosphatase. 2013 J. Atheroscler. Thromb. pmid:23518467
Okamoto H et al. Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21(WAF1). 2006 J. Atheroscler. Thromb. pmid:16908950
Reilly CM et al. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice. 2008 J. Autoimmun. pmid:18650065
Hildmann C et al. A new amidohydrolase from Bordetella or Alcaligenes strain FB188 with similarities to histone deacetylases. 2004 J. Bacteriol. pmid:15060035
Maruoka H et al. Low-molecular-weight compounds having neurotrophic activity in cultured PC12 cells and neurons. 2011 J. Biochem. pmid:21908547
Yamamoto I et al. Histone hyperacetylation plays a role in augmentation of IL-4-induced IgE production in LPS-stimulated murine B-lymphocytes by sodium butyrate. 1996 J. Biochem. pmid:8827437
Zhao W et al. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island. 2005 J. Biochem. pmid:15809347
Kook SH et al. Epstein-Barr virus-infected Akata cells are sensitive to histone deacetylase inhibitor TSA-provoked apoptosis. 2005 J. Biochem. Mol. Biol. pmid:16336792
Zhang Y and Zhang B Trichostatin A, an Inhibitor of Histone Deacetylase, Inhibits the Viability and Invasiveness of Hypoxic Rheumatoid Arthritis Fibroblast-Like Synoviocytes via PI3K/Akt Signaling. 2016 J. Biochem. Mol. Toxicol. pmid:26509796
Jin B and Ryu DY Regulation of CYP1A2 by histone deacetylase inhibitors in mouse hepatocytes. 2004 J. Biochem. Mol. Toxicol. pmid:15252868
Sanyal S et al. Differential regulation of the orphan nuclear receptor small heterodimer partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms. 2002 J. Biol. Chem. pmid:11705994
Galasinski SC et al. Global regulation of post-translational modifications on core histones. 2002 J. Biol. Chem. pmid:11709551
Yin L et al. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. 2001 J. Biol. Chem. pmid:11572859
Liou JS et al. Oncogenic ras mediates apoptosis in response to protein kinase C inhibition through the generation of reactive oxygen species. 2000 J. Biol. Chem. pmid:10967125
Sakai N et al. Involvement of histone acetylation in ovarian steroid-induced decidualization of human endometrial stromal cells. 2003 J. Biol. Chem. pmid:12609987
Kurtev V et al. Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases. 2004 J. Biol. Chem. pmid:15140878
Klampfer L et al. Requirement of histone deacetylase activity for signaling by STAT1. 2004 J. Biol. Chem. pmid:15123634
Fu M et al. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. 2004 J. Biol. Chem. pmid:15123687
Rigamonti D et al. Loss of huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators. 2007 J. Biol. Chem. pmid:17565993
Kuno A et al. Resveratrol improves cardiomyopathy in dystrophin-deficient mice through SIRT1 protein-mediated modulation of p300 protein. 2013 J. Biol. Chem. pmid:23297412
Phiel CJ et al. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. 2001 J. Biol. Chem. pmid:11473107
Jacob AL et al. Acetylation of steroidogenic factor 1 protein regulates its transcriptional activity and recruits the coactivator GCN5. 2001 J. Biol. Chem. pmid:11479297
Gregory RI et al. Inhibition of histone deacetylases alters allelic chromatin conformation at the imprinted U2af1-rs1 locus in mouse embryonic stem cells. 2002 J. Biol. Chem. pmid:11821379
Lim Y et al. Trichostatin A-induced detransformation correlates with decreased focal adhesion kinase phosphorylation at tyrosine 861 in ras-transformed fibroblasts. 2002 J. Biol. Chem. pmid:11821402
Wilson MA et al. The histone deacetylase inhibitor trichostatin A blocks progesterone receptor-mediated transactivation of the mouse mammary tumor virus promoter in vivo. 2002 J. Biol. Chem. pmid:11821430
Hattori N et al. Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. 2004 J. Biol. Chem. pmid:14761969
Christian M et al. Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140. 2004 J. Biol. Chem. pmid:14736873
Bu Y and Gelman IH v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex. 2007 J. Biol. Chem. pmid:17626016
Singal R et al. Methylation of promoter proximal-transcribed sequences of an embryonic globin gene inhibits transcription in primary erythroid cells and promotes formation of a cell type-specific methyl cytosine binding complex. 2002 J. Biol. Chem. pmid:11684679
Ammanamanchi S et al. Acetylated sp3 is a transcriptional activator. 2003 J. Biol. Chem. pmid:12837748
Shan J et al. ATF4-dependent regulation of the JMJD3 gene during amino acid deprivation can be rescued in Atf4-deficient cells by inhibition of deacetylation. 2012 J. Biol. Chem. pmid:22955275
Wang J et al. Histone deacetylase inhibitors suppress TF-kappaB-dependent agonist-driven tissue factor expression in endothelial cells and monocytes. 2007 J. Biol. Chem. pmid:17675290
Hishiki T et al. BCL3 acts as a negative regulator of transcription from the human T-cell leukemia virus type 1 long terminal repeat through interactions with TORC3. 2007 J. Biol. Chem. pmid:17644518
Lin AC et al. The N termini of Friend of GATA (FOG) proteins define a novel transcriptional repression motif and a superfamily of transcriptional repressors. 2004 J. Biol. Chem. pmid:15507435
Chang S and Pikaard CS Transcript profiling in Arabidopsis reveals complex responses to global inhibition of DNA methylation and histone deacetylation. 2005 J. Biol. Chem. pmid:15516340
Wang S and Zhu J The hTERT gene is embedded in a nuclease-resistant chromatin domain. 2004 J. Biol. Chem. pmid:15516693
Diamond SE and Gutierrez-Hartmann A The Pit-1beta domain dictates active repression and alteration of histone acetylation of the proximal prolactin promoter. 2000 J. Biol. Chem. pmid:10921928
Spallotta F et al. A nitric oxide-dependent cross-talk between class I and III histone deacetylases accelerates skin repair. 2013 J. Biol. Chem. pmid:23463510
Mogal AP et al. Haploinsufficient prostate tumor suppression by Nkx3.1: a role for chromatin accessibility in dosage-sensitive gene regulation. 2007 J. Biol. Chem. pmid:17602165
Wong CY et al. Epigenetic regulation of phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 gene expression in prostate cancer cells. 2011 J. Biol. Chem. pmid:21636851
Carmen AA et al. HDA1 and HDA3 are components of a yeast histone deacetylase (HDA) complex. 1996 J. Biol. Chem. pmid:8663039
Asoh S et al. The super anti-apoptotic factor Bcl-xFNK constructed by disturbing intramolecular polar interactions in rat Bcl-xL. 2000 J. Biol. Chem. pmid:10970895
Cong YS and Bacchetti S Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells. 2000 J. Biol. Chem. pmid:10986277
Su M et al. Recruitment of nuclear factor Y to the inverted CCAAT element (ICE) by c-Jun and E1A stimulates basal transcription of the bone sialoprotein gene in osteosarcoma cells. 2005 J. Biol. Chem. pmid:16087680
Milutinovic S et al. Proliferating cell nuclear antigen associates with histone deacetylase activity, integrating DNA replication and chromatin modification. 2002 J. Biol. Chem. pmid:11929879
Kijima M et al. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. 1993 J. Biol. Chem. pmid:8226751
Waterborg JH Dynamics of histone acetylation in Chlamydomonas reinhardtii. 1998 J. Biol. Chem. pmid:9765294
Simboeck E et al. A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors. 2010 J. Biol. Chem. pmid:20952396
Yamaguchi K et al. Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. 2005 J. Biol. Chem. pmid:15994313
Wooten LG and Ogretmen B Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide. 2005 J. Biol. Chem. pmid:15951564
Marks J et al. Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter. 2003 J. Biol. Chem. pmid:12791684
Asthana J et al. Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells. 2013 J. Biol. Chem. pmid:23798680
Liao M et al. Coactivator function of positive cofactor 4 (PC4) in Sp1-directed luteinizing hormone receptor (LHR) gene transcription. 2011 J. Biol. Chem. pmid:21193408
Hayakawa K et al. Epigenetic switching by the metabolism-sensing factors in the generation of orexin neurons from mouse embryonic stem cells. 2013 J. Biol. Chem. pmid:23625921
Liu CJ et al. Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis. 2004 J. Biol. Chem. pmid:15337766
Muralidhar SA et al. Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cells. 2011 J. Biol. Chem. pmid:21078662
Hayakawa F et al. Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis. 2008 J. Biol. Chem. pmid:18621739
Kawamura T et al. Acetylation of GATA-4 is involved in the differentiation of embryonic stem cells into cardiac myocytes. 2005 J. Biol. Chem. pmid:15764815
Hichino A et al. Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells. 2017 J. Biol. Chem. pmid:28057758
Johnson CA et al. Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis. 2001 J. Biol. Chem. pmid:11136718
Walia H et al. Histone acetylation is required to maintain the unfolded nucleosome structure associated with transcribing DNA. 1998 J. Biol. Chem. pmid:9603965
Yoshioka H et al. Nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) expression is increased by the histone deacetylase inhibitor trichostatin A. 2008 J. Biol. Chem. pmid:18801729
Sakamoto S et al. Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon-stimulated early response genes. 2004 J. Biol. Chem. pmid:15194680
Ng Y et al. Expression of the human myotonic dystrophy kinase-related Cdc42-binding kinase gamma is regulated by promoter DNA methylation and Sp1 binding. 2004 J. Biol. Chem. pmid:15194684